Sarytogan Graphite's IPO to list today; how are earlier listings faring?

2 min read | June 30, 2022 06:54 AM BST | By Ashish

Highlights

  • Sarytogan Graphite is set to make its ASX debut on Thursday.

  • Sarytogan Graphite raised AU$8.5 million via an IPO at an issue price of AU$0.20.

  • Sarytogan Graphite owns a graphite project in Central Kazakhstan.

Sarytogan Graphite Ltd (ASX:SGA) is scheduled make its ASX debut on Thursday (as per latest ASX data), with no specific listing time mentioned. Sarytogan Graphite raised AU$8.5 million through an initial public offering (IPO). The issue price was AU$0.20. Joint lead managers of the issue were Inyati Capital Pty and RM Corporate Finance Pty.

Sarytogan Graphite owns a graphite project in Central Kazakhstan, which is known to have a substantial concentration of graphite.

Chalkos and Synergen’s listings

Meanwhile, two other listings have been proposed for Thursday, namely Chalkos Metals Ltd (ASX:CKM) and Synergen Met Ltd (ASX:SH2). While the listing date for Chalkos has been pushed back to 20 July 2022 at 11 AM (AEST), the listing date for Synergen is to be announced.

A total capital of AU$8 million was raised by the copper explorer via an IPO at an issue price of AU$0.20. The lead manager of the issue was Viridian Capital Pty.

Meanwhile, Synergen Met raised AU$25 million via a public issue. The IPO had an issue price of AU$0.20. Lodge Corporate Pty was the lead manager of the issue. The company offers solutions to environmental challenges.

A few companies so far listed on the ASX in June

Note:

  • ASX codes are proposed only and may change without notice.
  • Listing dates are proposed dates for the first quotation of securities set out in the entity's prospectus or information memorandum.
  • Listing dates are expected dates for the first quotation of securities set by the ASX after the completion of admission procedures. These could change without any notice. Investors should contact companies directly for further clarity. 

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next